Predictions
Carbios S.A.
Start price
Target price
Perf. (%)
€55.30
08.02.21
08.02.21
-
18.01.25
18.01.25
-52.35%
12.01.24
12.01.24
Could be worthwhile Investment >10% per year
Société Générale S.A.
Start price
Target price
Perf. (%)
€17.25
08.02.21
08.02.21
-
08.02.22
08.02.22
103.33%
09.02.22
09.02.22
Aéroports de Paris S.A.
Start price
Target price
Perf. (%)
€95.55
27.01.21
27.01.21
€125.00
27.01.22
27.01.22
24.02%
28.01.22
28.01.22
Could be worthwhile Investment >10% per year
Fermentalg S.A.
Start price
Target price
Perf. (%)
€3.50
27.01.21
27.01.21
€3.80
-6.01%
10.03.21
10.03.21
Could be worthwhile Investment >10% per year
McPhy Energy S.A.
Start price
Target price
Perf. (%)
€35.05
25.01.21
25.01.21
-
25.01.22
25.01.22
-54.78%
06.08.21
06.08.21
Business model of the past or high risk
Higher risks for its business
Carbios S.A.
Start price
Target price
Perf. (%)
€51.70
25.01.21
25.01.21
€66.00
25.01.22
25.01.22
-24.10%
17.01.22
17.01.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Metabolic Explorer
Start price
Target price
Perf. (%)
€2.79
25.01.21
25.01.21
€3.10
25.01.22
25.01.22
50.36%
22.06.21
22.06.21
Could be worthwhile Investment >10% per year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Europlasma S.A.
Start price
Target price
Perf. (%)
€18,400
25.01.21
25.01.21
€100,000
25.01.22
25.01.22
-94.46%
26.01.22
26.01.22
Vivendi S.A.
Start price
Target price
Perf. (%)
€26.63
24.01.21
24.01.21
-
24.01.22
24.01.22
5.52%
24.03.21
24.03.21
Well known brand
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Crossject S.A.
Start price
Target price
Perf. (%)
€3.67
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-28.61%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€8.16
15.01.21
15.01.21
-
15.01.22
15.01.22
-63.58%
16.01.22
16.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group